Related references
Note: Only part of the references are listed.Targeting HER2-positive breast cancer: advances and future directions
Sandra M. Swain et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role
Francesca Sanguedolce et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
BARD1 mystery: tumor suppressors are cancer susceptibility genes
Yousef M. Hawsawi et al.
BMC CANCER (2022)
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Danijel Sikic et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres
Radwa Sharaf et al.
GENOME MEDICINE (2022)
Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
Thomas W. Flaig et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Non-muscle invasive bladder cancer biomarkers beyond morphology
Camilla De Carlo et al.
FRONTIERS IN ONCOLOGY (2022)
RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair
Rui Gou et al.
FRONTIERS IN ONCOLOGY (2022)
Interaction between HER2 and ATM predicts poor survival in bladder cancer patients
Nada Albarakati et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
Andrew Lee et al.
JOURNAL OF MEDICAL GENETICS (2022)
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang et al.
CANCERS (2022)
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Weiling Li et al.
BIOMARKER RESEARCH (2022)
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2021)
Rad50 promotes ovarian cancer progression through NF-kappa B activation
Yinuo Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
Qian Zhu et al.
NATURE COMMUNICATIONS (2021)
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer
Judit Borcsok et al.
CLINICAL CANCER RESEARCH (2021)
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
Jonas Herrmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
Klaudia Stempa et al.
CANCERS (2021)
Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
Dong Chen et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Cohesin Mutations in Cancer: Emerging Therapeutic Targets
Jisha Antony et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis
Kai Gan et al.
FRONTIERS IN ONCOLOGY (2021)
The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication
Madalena Tarsounas et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
High expression of RAD21 predicts poor survival in patients with operated non-small-cell lung cancer
Tao Zhu et al.
TUMORI JOURNAL (2020)
Literature Review ofBARD1as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
Wejdan M. Alenezi et al.
GENES (2020)
Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
Malwina Suszynska et al.
GENES (2020)
The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers
Andrea K. Watters et al.
GENES (2020)
Cohesin subunit RAD21: From biology to disease
Haizi Cheng et al.
GENE (2020)
Assessment of Luminal and Basal Phenotypes in Bladder Cancer
Charles C. Guo et al.
SCIENTIFIC REPORTS (2020)
Targeted Therapy in Metastatic Bladder Cancer: Present Status and Future Directions
Mathijs Scholtes et al.
APPLIED SCIENCES-BASEL (2020)
RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers
Adel Alblihy et al.
MOLECULAR BIOMEDICINE (2020)
Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers
Janakiraman Subramanian et al.
ONCOLOGIST (2019)
MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
Lei Bian et al.
MOLECULAR CANCER (2019)
Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2019)
Systematic Review: Targeting HER2 in Bladder Cancer
Vadim S. Koshkin et al.
BLADDER CANCER (2019)
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
Nana Weber-Lassalle et al.
BREAST CANCER RESEARCH (2019)
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients
Cong Fan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The effect of aberrant expression and genetic polymorphisms of Rad21 on cervical cancer biology
Li Xia et al.
CANCER MEDICINE (2018)
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Vincent Ho et al.
BMC CANCER (2018)
Activation of the DNA-repair mechanism through NBS1 and MRE11 diffusion
Ida Friis et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Targeting RAD50 increases sensitivity to radiotherapy in colorectal cancer cells
C. Chen et al.
NEOPLASMA (2018)
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer
Yifan Wang et al.
CLINICAL CANCER RESEARCH (2018)
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
Pablo Garcia-Sanz et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival
Vincent Ho et al.
CANCERS (2017)
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy
Bernhard Kiss et al.
SCIENTIFIC REPORTS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
Bolag Altan et al.
ANTICANCER RESEARCH (2016)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
20. RAD21 overexpression is frequently observed in prostate cancer
S. Deb et al.
PATHOLOGY (2016)
Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction
Angela N. Bartley et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas A Strobe-Compliant Study
Mo-Jin Wang et al.
MEDICINE (2015)
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
M. T. W. Teo et al.
ANNALS OF ONCOLOGY (2014)
RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
S. Deb et al.
BRITISH JOURNAL OF CANCER (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
Markus Riester et al.
CLINICAL CANCER RESEARCH (2014)
Cohesin in cancer: chromosome segregation and beyond
Ana Losada
NATURE REVIEWS CANCER (2014)
Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Gopa Iyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer
Jens R. Laurberg et al.
BJU INTERNATIONAL (2012)
Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
Markus Riester et al.
CLINICAL CANCER RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
Huiling Xu et al.
BREAST CANCER RESEARCH (2011)
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
Ananya Choudhury et al.
CANCER RESEARCH (2010)
ErbB2 requires integrin α5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells
Keneshia K. Haenssen et al.
JOURNAL OF CELL SCIENCE (2010)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
The cohesin complex and its roles in chromosome biology
Jan-Michael Peters et al.
GENES & DEVELOPMENT (2008)
GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function
Sara Mostafavi et al.
GENOME BIOLOGY (2008)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer
Karin Soderlund et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Katri Heikkinen et al.
CARCINOGENESIS (2006)
The Rad50 signature motif: Essential to ATP binding and biological function
G Moncalian et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
MRE11/RAD50/NBS1: complex activities
N Assenmacher et al.
CHROMOSOMA (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks
UK Westermark et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
